Status: Not yet recruiting
TILs Therapy for Multiple Primary Early-Stage NSCLC
This is a single-arm study aimed at evaluating the safety of TILs therapy for multiple primary early-stage NSCLC
Participants needed: 50
Trial details
Phase: Early Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Tianjin Medical University General HospitalUpdated: Mar 27, 2026
Eligibility criteria
Age 18-75 years, male or female; [+6]
Patients with pathological diagnosis of small cell lung cancer components; [+10]